Office of the Chief Medical Officer

**Mission** Support medical product development and availability, promote patient and consumer health and advance innovative clinical research. **What We Do** The Office of the Chief Medical Officer (OCMO) provides executive leadership, coordination, and oversight of FDA cross-cutting clinical and public health emergency-related regulatory policy matters, and public health preparedness and response activities on behalf of the Commissioner. OCMO promotes the development of safe, effective, and innovative medical products for patients by facilitating agency-wide collaboration on combination products, improving evidence generation practices, overseeing ethical conduct of clinical research, advancing the development of new treatments for rare diseases, assuring children have access to safe and effective medical products, and facilitating development and availability of medical countermeasures. OCMO fosters clinical community of practice and related career development across the agency and serves as primary liaison to clinical organizations.